17-48999124-A-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_006546.4(IGF2BP1):āc.191A>Gā(p.Gln64Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000394 in 1,394,658 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_006546.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IGF2BP1 | NM_006546.4 | c.191A>G | p.Gln64Arg | missense_variant | 2/15 | ENST00000290341.8 | NP_006537.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IGF2BP1 | ENST00000290341.8 | c.191A>G | p.Gln64Arg | missense_variant | 2/15 | 1 | NM_006546.4 | ENSP00000290341.3 | ||
IGF2BP1 | ENST00000431824.2 | c.191A>G | p.Gln64Arg | missense_variant | 2/13 | 1 | ENSP00000389135.2 | |||
IGF2BP1 | ENST00000510023.5 | n.451A>G | non_coding_transcript_exon_variant | 2/3 | 3 | |||||
IGF2BP1 | ENST00000515586.5 | n.174A>G | non_coding_transcript_exon_variant | 2/6 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000204 AC: 3AN: 147170Hom.: 0 Cov.: 27
GnomAD3 exomes AF: 0.0000442 AC: 11AN: 248866Hom.: 0 AF XY: 0.0000444 AC XY: 6AN XY: 135196
GnomAD4 exome AF: 0.0000394 AC: 55AN: 1394658Hom.: 0 Cov.: 29 AF XY: 0.0000504 AC XY: 35AN XY: 694556
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000204 AC: 3AN: 147170Hom.: 0 Cov.: 27 AF XY: 0.0000140 AC XY: 1AN XY: 71570
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 21, 2024 | The c.191A>G (p.Q64R) alteration is located in exon 2 (coding exon 2) of the IGF2BP1 gene. This alteration results from a A to G substitution at nucleotide position 191, causing the glutamine (Q) at amino acid position 64 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at